BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 38534310)

  • 1. Cannabidiol Exerts Anticonvulsant Effects Alone and in Combination with Δ
    Javadzadeh Y; Santos A; Aquilino MS; Mylvaganam S; Urban K; Carlen PL
    Cells; 2024 Mar; 13(6):. PubMed ID: 38534310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Motor effects of the non-psychotropic phytocannabinoid cannabidiol that are mediated by 5-HT1A receptors.
    Espejo-Porras F; Fernández-Ruiz J; Pertwee RG; Mechoulam R; García C
    Neuropharmacology; 2013 Dec; 75():155-63. PubMed ID: 23924692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabidiol Interferes with Establishment of Δ
    DeVuono MV; La Caprara O; Petrie GN; Limebeer CL; Rock EM; Hill MN; Parker LA
    Cannabis Cannabinoid Res; 2022 Feb; 7(1):58-64. PubMed ID: 33998876
    [No Abstract]   [Full Text] [Related]  

  • 4. Assessing the role of serotonergic receptors in cannabidiol's anticonvulsant efficacy.
    Pelz MC; Schoolcraft KD; Larson C; Spring MG; López HH
    Epilepsy Behav; 2017 Aug; 73():111-118. PubMed ID: 28624721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders.
    Devinsky O; Cilio MR; Cross H; Fernandez-Ruiz J; French J; Hill C; Katz R; Di Marzo V; Jutras-Aswad D; Notcutt WG; Martinez-Orgado J; Robson PJ; Rohrback BG; Thiele E; Whalley B; Friedman D
    Epilepsia; 2014 Jun; 55(6):791-802. PubMed ID: 24854329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of cannabidiol and Δ9-tetrahydrocannabinol, alone and in combination, in the maximal electroshock seizure model.
    Dlugosz L; Zhou HZ; Scott BW; Burnham M
    Epilepsy Res; 2023 Feb; 190():107087. PubMed ID: 36646020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions between cannabidiol and Δ
    Anderson LL; Low IK; McGregor IS; Arnold JC
    Br J Pharmacol; 2020 Sep; 177(18):4261-4274. PubMed ID: 32608111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology.
    Bhattacharyya S; Morrison PD; Fusar-Poli P; Martin-Santos R; Borgwardt S; Winton-Brown T; Nosarti C; O' Carroll CM; Seal M; Allen P; Mehta MA; Stone JM; Tunstall N; Giampietro V; Kapur S; Murray RM; Zuardi AW; Crippa JA; Atakan Z; McGuire PK
    Neuropsychopharmacology; 2010 Feb; 35(3):764-74. PubMed ID: 19924114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single and combined effects of plant-derived and synthetic cannabinoids on cognition and cannabinoid-associated withdrawal signs in mice.
    Myers AM; Siegele PB; Foss JD; Tuma RF; Ward SJ
    Br J Pharmacol; 2019 May; 176(10):1552-1567. PubMed ID: 29338068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of prior foot shock stress and Δ
    Rock EM; Limebeer CL; Petrie GN; Williams LA; Mechoulam R; Parker LA
    Psychopharmacology (Berl); 2017 Jul; 234(14):2207-2217. PubMed ID: 28424834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomised controlled trial of vaporised Δ
    Solowij N; Broyd S; Greenwood LM; van Hell H; Martelozzo D; Rueb K; Todd J; Liu Z; Galettis P; Martin J; Murray R; Jones A; Michie PT; Croft R
    Eur Arch Psychiatry Clin Neurosci; 2019 Feb; 269(1):17-35. PubMed ID: 30661105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabis for the Treatment of Epilepsy: an Update.
    Gaston TE; Szaflarski JP
    Curr Neurol Neurosci Rep; 2018 Sep; 18(11):73. PubMed ID: 30194563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of combined doses of Δ
    Rock EM; Sullivan MT; Pravato S; Pratt M; Limebeer CL; Parker LA
    Psychopharmacology (Berl); 2020 Mar; 237(3):901-914. PubMed ID: 31897571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabidiol for Oral Health: A New Promising Therapeutical Tool in Dentistry.
    Bellocchio L; Patano A; Inchingolo AD; Inchingolo F; Dipalma G; Isacco CG; de Ruvo E; Rapone B; Mancini A; Lorusso F; Scarano A; Malcangi G; Inchingolo AM
    Int J Mol Sci; 2023 Jun; 24(11):. PubMed ID: 37298644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using the BMD Approach to Derive Acceptable Daily Intakes of Cannabidiol (CBD) and Tetrahydrocannabinol (THC) Relevant to Electronic Cigarette Liquids.
    Hindelang P; Scharinger A; Richling E; Walch SG; Lachenmeier DW
    Front Biosci (Landmark Ed); 2022 Jul; 27(8):228. PubMed ID: 36042166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute effects of Δ
    Greenwood LM; Broyd SJ; van Hell HH; Todd J; Jones A; Murray RM; Croft RJ; Michie PT; Solowij N
    Psychopharmacology (Berl); 2022 May; 239(5):1409-1424. PubMed ID: 34719731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabidiol attenuates catalepsy induced by distinct pharmacological mechanisms via 5-HT1A receptor activation in mice.
    Gomes FV; Del Bel EA; Guimarães FS
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():43-7. PubMed ID: 23791616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Critical Review of the Role of the Cannabinoid Compounds Δ
    Jones É; Vlachou S
    Molecules; 2020 Oct; 25(21):. PubMed ID: 33113776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects on variable-interval performance in rats of delta 9-tetrahydrocannabinol and cannabidiol, separately and in combination.
    Zuardi AW; Karniol IG
    Braz J Med Biol Res; 1983 Jul; 16(2):141-6. PubMed ID: 6317104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabidiol for Pain Treatment: Focus on Pharmacology and Mechanism of Action.
    Mlost J; Bryk M; Starowicz K
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33238607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.